The Use of Cannabis for Treatment
The use of marijuana in any context is a highly (no pun intended) charged topic for cannabis treatment. That being said, medical marijuana has made its way onto the forefront of symptom management whether in the form of smoking or consumption of infused products like cookies, brownies, gummies, chocolate or oil, among others. Now, researchers in Western Australia are exploring how the plant can lessen the effects of Alzheimer’s and related dementias.
Researchers at the University of Notre Dame’s Institute for Health Research are partnering with MGC Pharmaceuticals for a series of 16 week trials taking place over 14 months. Industry officials and professionals of elder care and medicine are also supporting the groundbreaking and detailed study.
A specially-designed Cannabis product called CogniCann has been developed for the project in the form of an oral spray. The spray is a blend of THC, CBD and other cannabinoids with a specific ratio meant to treat the symptoms of Alzheimer’s and dementias, including improving cognitive functions related to these diseases and alleviating agitation and psychiatric symptoms.
Study on Cannabis Treatment
The trailblazing study will be randomized, double-blind and placebo-controlled. It is also a crossover study, meaning it is a longitudinal study in which participants will receive varying levels of exposure or treatment. The research team is starting with a small group of subjects-only 50 participants are estimated to be enrolled. Participants must be at least 65 years of age, have a diagnosis of mild Alzheimer’s or dementia and must be a resident of an elder care facility.